Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- F-1 Registration statement (foreign)
- 2.1 Exhibit 2.1
- 2.2 Exhibit 2.2
- 3.1 Exhibit 3.1
- 4.1 Exhibit 4.1
- 4.1.1 Exhibit 4.1.1
- 4.3 Exhibit 4.3
- 10.1 Exhibit 10.1
- 10.2 Exhibit 10.2
- 10.3 Exhibit 10.3
- 10.4 Exhibit 10.4
- 10.5 Exhibit 10.5
- 10.6 Exhibit 10.6
- 10.7 Exhibit 10.7
- 10.11.1 Exhibit 10.11.1
- 10.11.2 Exhibit 10.11.2
- 10.11.3 Exhibit 10.11.3
- 10.11.4 Exhibit 10.11.4
- 10.11.5 Exhibit 10.11.5
- 10.11.6 Exhibit 10.11.6
- 10.11.7 Exhibit 10.11.7
- 10.11.8 Exhibit 10.11.8
- 10.11.9 Exhibit 10.11.9
- 10.11.10 Exhibit 10.11.10
- 10.12.1 Exhibit 10.12.1
- 10.12.2 Exhibit 10.12.2
- 10.12.3 Exhibit 10.12.3
- 10.12.4 Exhibit 10.12.4
- 10.12.5 Exhibit 10.12.5
- 10.13 Exhibit 10.13
- 16.1 Exhibit 16.1
- 21.1 Exhibit 21.1
- 23.1 Exhibit 23.1
- 23.2 Exhibit 23.2
AMYT similar filings
Filing view
External links
Exhibit 23.2
CONSENT OF INDEPENDENT AUDITORS
We consent to the use in this Registration Statement on Form F-1 of our report dated February 18, 2020 relating to the financial statements of Aegerion Pharmaceuticals, Inc. We also consent to the reference to us under the heading "Experts" in such Registration Statement.
/s/ Deloitte & Touche LLP
Boston, Massachusetts
June 23, 2020